Nephrology

Relevant Content

Methodologic Standards for Follow-Up Extension in Cardiovascular Trials

Extension follow-up studies address long-term questions beyond the parent...

Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy

Polypharmacy is common in cardiovascular (CV) care because guideline-direc...

Researchers at Heart

uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome

Circulation Research, Volume 139, Issue 1, Page e328563, June 19, 2026. Strategies for Optimizing Heart Failure Care in the Older Adult

Heart failure (HF) in older adults is a growing and distinct clinical chal...

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome

Guideline offering updated evidence on cardiovascular‑kidney‑metabolic syn...

Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease

The American Heart Association Predicting Risk of Cardiovascular Disease E...

Repairing the Therapeutic Framework of Mineralocorticoid Receptor Signaling in HFpEF

Circulation Research, Volume 138, Issue 11, Page e328632, May 22, 2026. Endothelial DNA Damage Orchestrates Cardio-Kidney-Metabolic Dysfunction Through Endothelin-1 Signaling

Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print.
B...

Health Care Affordability in the United States, From Crisis to Action

U.S. health care costs exceed $5T yearly, driving delayed care and debt. E...